BioCentury
ARTICLE | Clinical News

Iressa gefitinib: Post-marketing study data

August 15, 2005 7:00 AM UTC

Data from tumor samples of 39 NSCLC patients showed a correlation between low expression levels of the epithelial membrane protein 1 ( EMP1) and the probability of high response to treatment (p=0.04)...